Massive new study aims to unlock secrets of chronic pancreatitis
NCT ID NCT03099850
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is following over 2,300 people across the US to better understand chronic pancreatitis, a painful long-term condition of the pancreas. Researchers will track participants' symptoms and disease changes over time to identify what causes the disease and how it progresses. The goal is to use this information to develop new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,345 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2017
- Expected to finish
-
Jun 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants recruited from external sites.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1\. Participants with chronic pancreatitis. Exclusion Criteria: ALL GROUPS EXCEPT GREEN GROUP I: 1. History of autoimmune or traumatic pancreatitis, or sentinel attack of acute necrotizing pancreatitis which results in suspected 2. Primary pancreatic tumors - pancreatic ductal adenocarcinoma, suspected cystic neoplasm (\>1 cms in size or main duct involvement), neuroendocrine tumors, and other uncommon tumors. 3. Pancreatic metastasis from other malignancies. 4. History of solid organ transplant, HIV/AIDS. 5. Known isolated pancreatic exocrine insufficiency (e.g. in the absence of any eligible inclusion criteria). 6. Participants must not have medical or psychiatric illnesses or ongoing substance abuse that in the investigator's opinion would compromise their ability to tolerate study interventions or participate in longitudinal follow up. 7. Patients with known abnormal creatinine (GFR \< 30) or renal failure (applies to patients with chronic upper abdominal pain of suspected pancreatic origin and suspected CP (Yellow) subgroups). 8. Failure to agree for longitudinal follow-up. 9. Known Pregnancy. All participants of childbearing potential, except if post-menopausal \[i.e. no menses for ≥2 years\] or had a hysterectomy, bilateral tubal ligation/clip (surgical sterilization) or surgical removal of both the ovaries), must have a negative urine or serum B-HCG pregnancy test documented within 2 days prior to any endoscopic or radiologic procedures done for research purposes. Any standard of care tests will follow institutional policies regarding pregnancy test. 10. Currently incarcerated. 11. Inability to get MRI/MRCP in patients with chronic abdominal pain of suspected pancreatic origin (Green II) or Suspected CP (Yellow groups) at baseline (e.g. metal object in the body which precludes performance of MRI).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pancreatitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77339, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could fasting ease the misery of pancreatitis?
- Chilling the pancreatic duct opening: can ice water cut Post-ERCP pancreatitis?
- Gut bacteria may hold clues to gallstone complications
- Can genes and environment together trigger pancreatic disease? a new biobank seeks answers
- Can a vast image library unlock better pancreatic diagnoses?
- Blood cell ratios may flag dangerous pancreatitis early